Sangamo Therapeutics
SGMO
#10606
Rank
โ‚ฌ27.44 M
Marketcap
0,06625ย โ‚ฌ
Share price
0.00%
Change (1 day)
-84.99%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2023 (TTM): -1,34ย โ‚ฌ

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,34ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,12ย โ‚ฌ a decrease over its 2021 EPS that were of -1,11ย โ‚ฌ.

EPS history for Sangamo Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,34ย โ‚ฌ19.79%
2022-1,12ย โ‚ฌ0.81%
2021-1,11ย โ‚ฌ33.33%
2020-0,83ย โ‚ฌ6.9%
2019-0,78ย โ‚ฌ22.54%
2018-0,64ย โ‚ฌ1.43%
2017-0,63ย โ‚ฌ-31.37%
2016-0,91ย โ‚ฌ75.86%
2015-0,52ย โ‚ฌ48.72%
2014-0,35ย โ‚ฌ-17.02%
2013-0,42ย โ‚ฌ9.3%
2012-0,38ย โ‚ฌ-39.44%
2011-0,64ย โ‚ฌ29.09%
2010-0,49ย โ‚ฌ22.22%
2009-0,40ย โ‚ฌ-25%
2008-0,54ย โ‚ฌ3.45%
2007-0,52ย โ‚ฌ5.45%
2006-0,49ย โ‚ฌ10%
2005-0,45ย โ‚ฌ-9.09%
2004-0,49ย โ‚ฌ30.95%
2003-0,38ย โ‚ฌ-65.29%
2002-1,08ย โ‚ฌ15.24%
2001-0,94ย โ‚ฌ3.96%
2000-0,90ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,98ย โ‚ฌ-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,56ย โ‚ฌ-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2,11ย โ‚ฌ-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-1,14ย โ‚ฌ 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,78ย โ‚ฌ 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,89ย โ‚ฌ-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
17,74ย โ‚ฌ-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08058ย โ‚ฌ-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA